These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8847155)

  • 21. Interaction between propranolol and amino acids in the single-pass isolated, perfused rat liver.
    Semple HA; Xia F
    Drug Metab Dispos; 1995 Aug; 23(8):794-8. PubMed ID: 7493544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolite profiling study of propranolol in rat using LC/MS/MS analysis.
    Beaudry F; Yves Le Blanc JC; Coutu M; Ramier I; Moreau JP; Brown NK
    Biomed Chromatogr; 1999 Aug; 13(5):363-9. PubMed ID: 10425029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro cutaneous biotransformation of propranolol.
    Cormier M; Ledger PW; Marty JP; Amkraut A
    J Invest Dermatol; 1991 Sep; 97(3):447-53. PubMed ID: 1875045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stereoselective pharmacokinetics of oxprenolol, propranolol, and verapamil: species differences and influence of endotoxin.
    Laethem ME; Belpaire FM; Wijnant P; Bogaert MG
    Chirality; 1995; 7(8):616-22. PubMed ID: 8593255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The lack of effect of aerobic exercise training on propranolol pharmacokinetics in young and elderly adults.
    Panton LB; Guillen GJ; Williams L; Graves JE; Vivas C; Cediel M; Pollock ML; Garzarella L; Krumerman J; Derendorf H
    J Clin Pharmacol; 1995 Sep; 35(9):885-94. PubMed ID: 8786248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Propranolol metabolism in normal subjects: association with sex steroid hormones.
    Walle T; Walle K; Mathur RS; Palesch YY; Conradi EC
    Clin Pharmacol Ther; 1994 Aug; 56(2):127-32. PubMed ID: 8062488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of in vitro biotransformation of propranolol with HPLC, MS/MS, and two bioassays.
    Nałecz-Jawecki G; Wójcik T; Sawicki J
    Environ Toxicol; 2008 Feb; 23(1):52-8. PubMed ID: 18214929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The liver and aging. The effect of age on liver function and drug metabolism].
    Kuntz HD; Femfert U; May B
    Dtsch Med Wochenschr; 1987 May; 112(19):757-9. PubMed ID: 3582184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolism and excretion of the novel antipsychotic drug ziprasidone in rats after oral administration of a mixture of 14C- and 3H-labeled ziprasidone.
    Prakash C; Kamel A; Anderson W; Howard H
    Drug Metab Dispos; 1997 Feb; 25(2):206-18. PubMed ID: 9029052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of hepatic impairment on the pharmacokinetics of atomoxetine and its metabolites.
    Chalon SA; Desager JP; Desante KA; Frye RF; Witcher J; Long AJ; Sauer JM; Golnez JL; Smith BP; Thomasson HR; Horsmans Y
    Clin Pharmacol Ther; 2003 Mar; 73(3):178-91. PubMed ID: 12621383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension.
    Zineh I; Beitelshees AL; Gaedigk A; Walker JR; Pauly DF; Eberst K; Leeder JS; Phillips MS; Gelfand CA; Johnson JA
    Clin Pharmacol Ther; 2004 Dec; 76(6):536-44. PubMed ID: 15592325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disposition of lasofoxifene, a next-generation selective estrogen receptor modulator, in healthy male subjects.
    Prakash C; Johnson KA; Gardner MJ
    Drug Metab Dispos; 2008 Jul; 36(7):1218-26. PubMed ID: 18372400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolism and excretion of a new anxiolytic drug candidate, CP-93, 393, in healthy male volunteers.
    Prakash C; Cui D; Baxter JG; Bright GM; Miceli J; Wilner K
    Drug Metab Dispos; 1998 May; 26(5):448-56. PubMed ID: 9571226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma kinetics, metabolism, and urinary excretion of alpha-lipoic acid following oral administration in healthy volunteers.
    Teichert J; Hermann R; Ruus P; Preiss R
    J Clin Pharmacol; 2003 Nov; 43(11):1257-67. PubMed ID: 14551180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stereoselectivity and interaction between the glucuronidation of S-(-)- and R-(+)-propranolol in rat hepatic microsomes pretreated with different inducers.
    Luan LJ; Shao Q; Zeng S
    Pharmazie; 2005 Mar; 60(3):221-4. PubMed ID: 15801678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neonatal hepatic propranolol elimination: studies in the isolated perfused neonatal sheep liver.
    Gow PJ; Treepongkaruna S; Ghabrial H; Shulkes A; Smallwood RA; Morgan DJ; Ching MS
    J Pharm Sci; 2000 May; 89(5):586-93. PubMed ID: 10756324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative pharmacokinetics of propranolol and atenolol in primary hyperlipidemia.
    Telatyńska B; Wójcicki J; Droździk M; Gawrońska-Szklarz B; Sulzyc-Bielicka V; Sterna R
    Pol J Pharmacol; 2003; 55(1):81-9. PubMed ID: 12856830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stereoselective urinary excretion of S-(-)- and R-(+)-propranolol glucuronide following oral administration of RS-propranolol in Chinese Han subjects.
    Luan LJ; Shao Q; Ma JY; Zeng S
    World J Gastroenterol; 2005 Mar; 11(12):1822-4. PubMed ID: 15793873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antipyrine kinetics in the elderly: prediction of age-related changes in benzodiazepine oxidizing capacity.
    Greenblatt DJ; Divoll M; Abernethy DR; Harmatz JS; Shader RI
    J Pharmacol Exp Ther; 1982 Jan; 220(1):120-6. PubMed ID: 7053408
    [No Abstract]   [Full Text] [Related]  

  • 40. Stereoselective ring oxidation of propranolol in man.
    Walle T; Walle UK; Wilson MJ; Fagan TC; Gaffney TE
    Br J Clin Pharmacol; 1984 Nov; 18(5):741-8. PubMed ID: 6508983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.